Does SIMVASTATIN Cause Hypophosphataemia? 144 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Hypophosphataemia have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.5% of all adverse event reports for SIMVASTATIN.
144
Reports of Hypophosphataemia with SIMVASTATIN
0.5%
of all SIMVASTATIN reports
122
Deaths
136
Hospitalizations
How Dangerous Is Hypophosphataemia From SIMVASTATIN?
Of the 144 reports, 122 (84.7%) resulted in death, 136 (94.4%) required hospitalization, and 109 (75.7%) were considered life-threatening.
Is Hypophosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Hypophosphataemia?
FERRIC CARBOXYMALTOSE (1,046)
ADEFOVIR DIPIVOXIL (368)
DENOSUMAB (322)
ZOLEDRONIC ACID (235)
LAMIVUDINE (205)
CYCLOPHOSPHAMIDE (196)
TENOFOVIR DISOPROXIL (192)
DEXAMETHASONE (186)
ACETAMINOPHEN (169)
LANSOPRAZOLE (159)
Which SIMVASTATIN Alternatives Have Lower Hypophosphataemia Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS